Advertisement

Latest News

ABCs in Dermatology: Our Hosts' Journeys to Dermatology

7 minutes ago

Hosts reveal how research, mentors, and clinic rotations spark a passion for skin disease and what makes dermatology unique.

Psychedelics Expand Options, Not Efficacy, in Depression Care, With Balázs Szigeti, PhD

3 hours ago

Findings suggest psychedelics match antidepressants for symptom relief, with future research needed on real-world use and functional outcomes.

GLP-1 Discontinuation Tied to Loss of Cardiovascular Protection

4 hours ago

GLP-1 discontinuation increases major adverse cardiovascular event risk in type 2 diabetes, highlighting the need for continuous therapy to sustain cardiometabolic benefit.

COPD Biologics in Practice: Exacerbation Reduction is No Longer Enough

5 hours ago

Clinicians compare newest asthma/COPD biologics, highlighting dupilumab’s edge, biomarker shifts, and insurance barriers shaping real-world use.

Key Points on Icotrokinra Following FDA Approval for Psoriasis, With Linda Stein Gold, MD

6 hours ago

Linda Stein Gold, MD, shares her perspective on the clinical significance of icotrokinra's FDA approval and what dermatologists need to know.

Advertisement
Advertisement